Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to compare cryobiopsies with forceps biopsies during semirigid thoracoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Nov 2011
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 16, 2011
CompletedFirst Posted
Study publicly available on registry
November 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedSeptember 10, 2015
September 1, 2015
3 years
November 16, 2011
September 8, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of forceps biopsy and cryobiopsy samples
* diagnostic yield * size of the biopsy specimens in mm2 * interpretability of biopsy specimens in histopathology terms: 1. easily interpretable (enough tissue with all elements required for diagnosis) 2. interpretable with some difficulty (less tissue or diagnostic elements - diagnosis less reliable) 3. interpretable with great difficulty (little tissue or scarce diagnostic elements - low reliability of diagnosis) 4. non-interpretable (diagnosis not possible) * assessment of biopsy-related artifacts by describing the amount of unaltered tissue in quartiles
12 month
Secondary Outcomes (1)
Safety
1 month
Study Arms (1)
Cryobiopsy, forceps biopsy
EXPERIMENTALCryoiopsies will be obtained by flexible autoclavable cryoprobe 20416-032 (Erbokryo CA, ERBE, Germany) with 2.4 mm in diameter. The tip of the probe is cooled to -890C with nitrous oxide within seconds after footswitch activation. Forceps biopsies will be obtained by flexible FB-55CD-1 Olympus forceps.
Interventions
The tip of the cryoprobe will be attached to suspicious part of parietal pleura and activated by footswitch for 3 seconds. The frozen tissue is going to be extracted by gently pulling of the probe. The probe with the attached biopsy sample is going to be removed together with the thoracoscope through trocar. The biopsy sample will be released from the probe by thawing in the saline. Forceps biopsy will be performed on usual way.
Eligibility Criteria
You may qualify if:
- or more years old
- unilateral pleural effusion of unknown origin
- pleural irregularities suspicious for pleural malignancy
- referral for thoracoscopy after less invasive means of diagnosis had failed
You may not qualify if:
- uncontrolled bleeding tendency
- unstable cardiovascular status
- severe heart failure
- ECOG performance status 4
- persistent hypoxemia after evacuation of pleural fluid
- pleural symphisis, fibrothorax
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Clinic Golnik
Golnik, Golnik, 4204, Slovenia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ales Rozman, MD
University Clinic Golnik
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
November 16, 2011
First Posted
November 21, 2011
Study Start
November 1, 2011
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
September 10, 2015
Record last verified: 2015-09